Jerry R Greenfield

SHIFTing goals in cystic fibrosis—managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium

T. Gonska, M. Putman, C. Verge, 2024, Pediatric Pulmonology.

Geographic variation in sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia

M. Falster, A. Havard, B. Neuen, 2024, Diabetes, obesity & metabolism.